USA Financial Formulas’s Biogen BIIB Stock Holding History

USA Financial Formulas’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$767K	Buy	+3,548	New	+$679K	0.14%	50
2024 Q3	–	Sell	-6	Closed	-$1.39K	–	277
2024 Q2	$1.39K	Hold	6	–	–	﹤0.01%	291
2024 Q1	$1.29K	Sell	6 -36	-86%	-$8.43K	﹤0.01%	298
2023 Q4	$10.9K	Sell	42 -8,504	-100%	-$2.09M	﹤0.01%	252
2023 Q3	$2.2M	Buy	8,546 +38	+0.4%	+$10.2K	3.28%	5
2023 Q2	$2.42M	Sell	8,508 -3,977	-32%	-$1.18M	3.72%	3
2023 Q1	$3.47M	Buy	+12,485	New	+$3.45M	5.62%	1
2022 Q3	$6K	Buy	24 +19	+380%	+$4.04K	0.01%	120
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	237
2022 Q1	$1K	Buy	+5	New	+$1.09K	﹤0.01%	272
2021 Q4	–	Sell	-3,595	Closed	-$1.02M	–	379
2021 Q3	$1.02M	Buy	+3,595	New	+$1.18M	0.91%	56
2020 Q4	–	Sell	-26	Closed	-$7K	–	326
2020 Q3	$7K	Sell	26 -19	-42%	-$5.3K	0.01%	162
2020 Q2	$12K	Sell	45 -11,600	-100%	-$3.49M	0.01%	76
2020 Q1	$3.68M	Buy	+11,645	New	+$3.53M	2.35%	5
2019 Q1	–	Sell	-14,571	Closed	-$5.15M	–	143
2018 Q4	$5.15M	Buy	+14,571	New	+$4.65M	1.28%	22
2018 Q1	–	Sell	-12,849	Closed	-$4.09M	–	316
2017 Q4	$4.09M	Buy	+12,849	New	+$4.12M	0.97%	28

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

USA Financial Formulas's BIIB Position: Q2 2026 in Review

USA Financial Formulas opened a new position in Biogen (BIIB) in Q2 2026: 3,548 shares worth $767K. The stake represents 0.14% of the portfolio and ranks #50 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in BIIB as recently as Q2 2024.

USA Financial Formulas first reported a position in BIIB in Q4 2017 and has held it in 16 quarters since. The position peaked at $5.15M in Q4 2018. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

USA Financial Formulas held 3,548 shares of Biogen worth $767K as of Q2 2026.
Biogen was a new USA Financial Formulas position in Q2 2026.
Biogen made up 0.14% of USA Financial Formulas's portfolio in Q2 2026, its #50 holding.
USA Financial Formulas first reported a position in Biogen in Q4 2017 and has held it in 16 quarters since.
USA Financial Formulas's Biogen position peaked at $5.15M in Q4 2018.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.